SEC Form 4 · accession 0001127602-17-033936
BIOGEN INC. · BIIB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregory F Covino
Officer — VP, Chief Accounting Officer
Period of report
Dec 1, 2017
Accepted (ET)
Dec 5, 2017 · 4:36 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875045
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 1, 2017 | F | 54 | $319.35 | D | 4,542 | D | |
| Common Stock | Dec 1, 2017 | F | 103 | $319.35 | D | 4,439 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 86.155 shares and 5.382 shares acquired under the Biogen Inc. employee stock purchase plan on 3/31/2017 and 6/30/2017, respectively.